Valuation: Cannabis Bioscience International Holdings, Inc.

Market Cap 2.37M 2.05M 1.92M 1.75M 3.28M 226M 3.34M 22.53M 8.81M 113M 8.89M 8.7M 377M P/E 2024
-9.52x
P/E 2025 -11.8x
Enterprise Value 3.37M 2.91M 2.74M 2.49M 4.67M 321M 4.76M 32.05M 12.53M 161M 12.64M 12.37M 537M EV / Sales 2024
28.9x
EV / Sales 2025 25.6x
Free-Float
41.59%
Yield 2024 *
-
Yield 2025 -
07-15 Cannabis Bioscience International Holdings Receives Texas License for Consumable Hemp Products CI
04-16 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 CI
02-19 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2025 CI
25-10-22 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025 CI
25-10-06 Cannabis Bioscience International Holdings, Inc Appoints Andy Trivedi to Its Board of Directors CI
25-09-22 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Full Year Ended May 31, 2025 CI
25-09-21 Cannabis Bioscience International Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
25-04-22 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2025 CI
25-01-21 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024 CI
25-01-06 Cannabis Bioscience International Holdings Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products CI
24-12-26 Cannabis Bioscience International Holdings, Inc. announced that it has received $0.075 million in funding CI
24-11-26 Cannabis Bioscience International Holdings, Inc. Appoints Charles Tamburello as Directors, Effective December 1, 2024 CI
24-11-25 Cannabis Bioscience International Holdings, Inc. Unveils the Future of Wellness with Revolutionary Anti-Aging Chip CI
1 week+100.00%
Current month+100.00%
1 month+50.00%
6 months-25.00%
Current year-40.00%
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0.01
10 years 0
Extreme 1.0E-6
0.27
Manager TitleAgeSince
Chief Executive Officer 70 2019-12-18
Treasurer 61 2024-05-05
Corporate Secretary 66 2019-12-18
Director TitleAgeSince
Director/Board Member 70 2019-12-18
Director/Board Member 66 2019-12-18
Director/Board Member 61 2024-05-05
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+100.00%-40.00%-31.03% 2.41M
-1.78%-1.68%+1.48%+15.31% 48.42B
+0.85%-0.70%+460.88%+563.55% 43.66B
-2.40%-0.23%+8.13%+71.41% 39.51B
-2.01%-0.85%+23.85%+8.73% 38.95B
-0.50%+0.85%+20.60%+49.65% 32.61B
+0.38%-3.23% - - 16.32B
-0.59%-2.06%+26.35%+118.09% 16.15B
+0.49%+0.92%+4.11%+23.67% 14.16B
-0.43%+4.70%+78.74%+33.31% 13.37B
Average -0.60%+0.44%+64.90%+94.74% 26.31B
Weighted average by Cap. -0.91%+0.59%+95.83%+132.95%

Financials

2024 2025
Net sales 249K 215K 202K 184K 345K 23.74M 351K 2.37M 926K 11.9M 934K 914K 39.64M 303K 262K 246K 224K 420K 28.91M 428K 2.88M 1.13M 14.49M 1.14M 1.11M 48.27M
Net income -651K -563K -529K -481K -904K -62.15M -920K -6.2M -2.42M -31.16M -2.44M -2.39M -104M -549K -475K -446K -406K -761K -52.37M -775K -5.22M -2.04M -26.25M -2.06M -2.02M -87.43M
Net Debt 939K 812K 763K 694K 1.3M 89.63M 1.33M 8.94M 3.49M 44.93M 3.53M 3.45M 150M 1M 865K 813K 739K 1.39M 95.46M 1.41M 9.52M 3.72M 47.85M 3.75M 3.67M 159M
Logo Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc. is engaged in the provision of services in therapeutic areas of clinical research. The Company provides educational systems focused on medical cannabis in the United States and Latin America, as well as worldwide through online education, services in therapeutic areas of clinical trials. Through its Alpha Research Business, based in Houston, Texas, it offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. Through the Pharmacology University Business, it provides knowledge and promotes professionalism in the worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. It offers multilevel educational services to entrepreneurs, medical and legal professionals, cultivators, dispensary technicians, manufacturers, patients, and others who desire to participate in the cannabis industry.
Employees
2
Date Price Change Volume
26-08-14 US$0.000200 -.--% 530,000
26-08-12 US$0.000200 +100.00% 851,000
26-08-11 US$0.000100 -33.33% 716,600
26-08-10 US$0.000150 -.--% 11,000
  1. Stock Market
  2. Stocks
  3. CBIH Stock